Biomarcadores y dianas terapéuticas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Ciérvide R, Manchón R, Ángel D, Quiles B, Rodríguez G, Veiras M, Blanco J, Diaz FM, Del Portillo EG, Monroy JL, Larrea L, Expósito J, Aristu J, Benavente S, Corrales-García E, Prieto C, García ME, Payano S, Perez MJ, Miguel IS, de la Pinta C, Díaz L, Mascias VM, Villarreal CLM, López M, Martínez FJ, Peña M, García R.
Stereotactic radiosurgery practice patterns for brain metastases: a survey by the SRS_SBRT_SEOR (Spanish Society of Radiation Oncology) Working Group.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY . 30(4): 513-522.
-
Kuncman L, la Pinta C, Milder MTW, Romero AM, Guckenberger M, Franzese C, Scorsetti M, Bruc B, Verellen D, Tanadini-Lang S.
Definition and requirements for stereotactic radiotherapy: a systematic review.
RADIOTHERAPY AND ONCOLOGY . 211: 111107-111107.
-
Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De La Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T.
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group.
Lung Cancer . 207: 108671-108671.
-
Audisio A, Gallio C, Velenik V, Meillat H, Ruiz-Garcia E, Riesco MC, Alecha JS, Rasschaert G, Carvalho C, Randrian V, Kirac I, Hernando J, Artaç M, O'Connor JM, Waldhorn I, Braam PM, Shamseddine A, Moretto R, de la Pinta C, De Felice F, Dulskas A, Páez López-Bravo D, Vanden Bulcke A, Bock F, Deleporte A, Van Den Eynde M, Geboes KP, Loi M, Messina M, Houlzé-Laroye C, Puccini A, Pastorino A, Papamichael D, Fiore M, Sur D, Eid M, Antoun C, Salati M, Garajovà I, Jakubauskas M, Tomášek J, Sousa Pinto CM, Schwingel J, Morano F, Adams RA, Dermine A, Chau A, Javed MA, Ghidini M, Fiorica F, Montenegro P, Petrillo A, Spolverato G, Mulet Margalef N, Diaz M, Baratelli C, Puleo F, Karampeazis A, Sert F, Gilliaux Q, De Stefano A, Liberale G, Moretti L, Martinive P, Deltuvaite Thomas V, Staggs V, Saad ED, Van Laethem JL, Sclafani F.
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
JAMA Oncology . 11(9): 1045-1054.
-
Paniagua-Iglesias P, Rincón-Ferrari MD, Candela-Toha A, Marcos-Jubilar M, Barquero-Lopez M, Gich-Saladich I, Medina-Marrero L, Bosch-Llobet A, Garrido-Fleischmann D, Ordoñez-Llanos J, Urrutia-Cuchí G.
Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival.
Journal Of Clinical Medicine . 14(13): .
-
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Roberto Robles N, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ.
A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study.
Nefrologia . 45(5): 360-368.
-
Hewitt E, Bouche G, Alencar AC, Bigelsen SJ, Radu R, Stoyanova-Beninska V, Carrato A, Valsecchi F, Soler Cantón A, van der Meer HG, García Bermejo ML, Budillon A, Cardone L, Rooman I, Platteeuw H, Baijet J, Fuchs C.
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
Cancer Management And Research . 17: 429-440.
-
Bara-Ledesma N, Viteri-Noel A, Lopez Rodriguez M, Stamatakis K, Fabregate M, Vazquez-Santos A, Gomez Del Olmo V.
Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(2): .
-
Piredda R, Martínez LGR, Stamatakis K, Martinez-Ortega J, Ferráz AL, Almendral JM, Revilla Y.
Assessment of molecular modulation by multifrequency electromagnetic pulses to preferably eradicate tumorigenic cells.
SCIENTIFIC REPORTS . 14(1): 30150-30150.
-
González-Lafuente L, Mercado-García E, Vázquez-Sánchez S, González-Moreno D, Boscá L, Fernández-Velasco M, Segura J, Kuro-O M, Ruilope LM, Liaño F, Ruiz-Hurtado G.
Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation.
Nefrologia . 44(6): 818-829.
-
Gonzalez-Lafuente, Laura, Mercado-Garcia, Elisa, Vazquez-Sanchez, Sara, Gonzalez-Moreno, Daniel, Bosca, Lisardo, Fernandez-Velasco, Maria, Segura, Julian, Kuro-O, Makoto, Ruilope, Luis M., Liano, Fernando, Ruiz-Hurtado, Gema.
Interleukin-6 as a prognostic marker in acute renal injury and its klotho-dependent regulation
NEFROLOGIA . 44(6): 818-829.
-
Budillon A, Leone A, Passaro E, Silvestro L, Foschini F, Iannelli F, Roca MS, Macchini M, Bruzzese F, Garcia Bermejo ML, Rodriguez Garrote M, Tortora G, Milella M, Reni M, Fuchs C, Hewitt E, Kubiak C, Di Gennaro E, Giannarelli D, Avallone A.
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.
Bmc Cancer . 24(1): 1167-1167.
-
Hernando-Requejo O, Olombrada MVT, Bravo IA, Moreno LA, López-Campos F, Gonzalez ML, Martín MM, Macías VM, de la Pinta C.
Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY . 29(3): 340-347.
-
Nagore D, Candela A, Bürge M, Tamayo E, Murie-Fernández M, Vives M, Monedero P, Álvarez J, Mendez E, Pasqualetto A, Mon T, Pita R, Varela MA, Esteva C, Pereira MA, Sanchez J, Rodriguez MA, Garcia A, Carmona P, López M, Pajares A, Vicente R, Aparicio R, Gragera I, Calderón E, Marcos JM, Gómez L, Rodríguez JM, Matilla A, Medina A, Hernández A, Morales L, Santana L, Garcia E, Montesinos S, Muñoz P, Bravo B, Blanco V.
Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study.
Revista Espanola De Anestesiologia Y Reanimacion . 71(7): 514-521.
-
López-Gil JC, García-Silva S, Ruiz-Cañas L, Navarro D, Palencia-Campos A, Giráldez-Trujillo A, Earl J, Dorado J, Gómez-López G, Monfort-Vengut A, Alcalá S, Gaida MM, García-Mulero S, Cabezas-Sáinz P, Batres-Ramos S, Barreto E, Sánchez-Tomero P, Vallespinós M, Ambler L, Lin ML, Aicher A, García García de Paredes A, de la Pinta C, Sanjuanbenito A, Ruz-Caracuel I, Rodríguez-Garrote M, Guerra C, Carrato A, de Cárcer G, Sánchez L, Nombela-Arrieta C, Espinet E, Sanchez-Arevalo Lobo VJ, Heeschen C, Sainz B Jr.
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.
Gut . 73(9): 1489-1508.
-
Hinojar R, Moreno-Gómez-Toledano R, Conde E, Gonzalez-Gomez A, García-Martin A, González-Portilla P, Fernández-Golfín C, García-Bermejo ML, Zaragoza C, Zamorano JL.
Circulating miRNA in functional tricuspid regurgitation. Unveiling novel links to heart failure: A pilot study.
ESC heart failure . 11(4): 2272-2286.
-
Meersch M, Weiss R, Strauß C, Albert F, Booke H, Forni L, Pittet JF, Kellum JA, Rosner M, Mehta R, Bellomo R, Rosenberger P, Zarbock A.
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.
INTENSIVE CARE MEDICINE . 50(2): 247-257.
-
Lacalle-Gonzalez C, Florez-Cespedes M, Sanz-Criado L, Ochieng' Otieno M, Ramos-Muñoz E, Fernandez-Aceñero MJ, Ortega-Medina L, Garcia-Foncillas J, Martinez-Useros J.
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer.
Biomedicines . 11(10): . Nº de citas: 4